Carlo Rinaldi

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Transforming Growth Factor

Top Venues

Nanoscale advances

Acta neuropathologica

Science advances

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anna J Kordala, Jessica Stoodley, Nina Ahlskog, Muhammad Hanifi, Antonio Garcia-Guerra, Amarjit Bhomra, Wooi Fang Lim, Lyndsay M Murray, Kevin Talbot, Suzan M Hammond, Matthew Ja Wood, Carlo Rinaldi
PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice. EMBO molecular medicine (2023)
Antonio Garcia-Guerra, Ruth Ellerington, Jens Gaitzsch, Jonathan Bath, Mahnseok Kye, Miguel A Varela, Giuseppe Battaglia, Matthew John Andrew Wood, Raquel Manzano, Carlo Rinaldi, Andrew J Turberfield
A modular RNA delivery system comprising spherical nucleic acids built on endosome-escaping polymeric nanoparticles. Nanoscale advances 5 (11) (2023)
Mitra Forouhan, Wooi Fang Lim, Laura C Zanetti-Domingues, Christopher J Tynan, Thomas C Roberts, Bilal Malik, Raquel Manzano, Alfina A Speciale, Ruth Ellerington, Antonio Garcia-Guerra, Pietro Fratta, Gianni Sorarú, Linda Greensmith, Maria Pennuto, Matthew J A Wood, Carlo Rinaldi
AR cooperates with SMAD4 to maintain skeletal muscle homeostasis. Acta neuropathologica 143 (6) (2022)
Wooi Fang Lim, Mitra Forouhan, Thomas C Roberts, Jesse Dabney, Ruth Ellerington, Alfina A Speciale, Raquel Manzano, Maria Lieto, Gavinda Sangha, Subhashis Banerjee, Mariana Conceição, Lara Cravo, Annabelle Biscans, Loïc Roux, Naemeh Pourshafie, Christopher Grunseich, Stephanie Duguez, Anastasia Khvorova, Maria Pennuto, Constanza J Cortes, Albert R La Spada, Kenneth H Fischbeck, Matthew John Andrew Wood, Carlo Rinaldi
Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity. Science advances 7 (34) (2021)